Submit Feedback
Revenue breakdown by Products & Services
Revenue breakdown by Geography

Abbott Laboratories's Revenue by Region

In fiscal year , Abbott Laboratories's revenue by geographical region are as follows:


Learn more about Abbott Laboratories’s Revenue by Products

Check out competitors to Abbott Laboratories in a side-by-side comparison.

Explore additional financial metrics for Abbott Laboratories.

Continue reading...

The above chart shows Abbott Laboratories's revenue percentage share by geographical region.

In fiscal year 2022, Abbott Laboratories's revenue by region is as follows:

  • C [H] generated $2.13B in revenue, representing 4.89% of its total revenue.
  • CANADA generated $1.28B in revenue, representing 2.93% of its total revenue.
  • GERMANY generated $2.34B in revenue, representing 5.36% of its total revenue.
  • INDIA generated $1.65B in revenue, representing 3.78% of its total revenue.
  • JAPAN generated $1.93B in revenue, representing 4.43% of its total revenue.
  • Non-US generated $14.84B in revenue, representing 34% of its total revenue.
  • SWITZERLAND generated $1.34B in revenue, representing 3.06% of its total revenue.
  • UNITED STATES generated $18.14B in revenue, representing 41.56% of its total revenue.

The biggest region for Abbott Laboratories is the UNITED STATES, which represents 41.56% of its total revenue.
The smallest region for Abbott Laboratories is the CANADA, which represents 2.93% of its total revenue.

The above chart shows Abbott Laboratories's revenue percentage share by geographical region.

In fiscal year 2023, Abbott Laboratories's revenue by region is as follows:

  • C [H] generated $2.25B in revenue, representing 5.62% of its total revenue.
  • GERMANY generated $2.35B in revenue, representing 5.85% of its total revenue.
  • INDIA generated $1.75B in revenue, representing 4.36% of its total revenue.
  • JAPAN generated $1.51B in revenue, representing 3.77% of its total revenue.
  • NETHERLANDS generated $1.07B in revenue, representing 2.68% of its total revenue.
  • Non-US generated $14.08B in revenue, representing 35.11% of its total revenue.
  • SWITZERLAND generated $1.64B in revenue, representing 4.08% of its total revenue.
  • UNITED STATES generated $15.45B in revenue, representing 38.53% of its total revenue.

The biggest region for Abbott Laboratories is the UNITED STATES, which represents 38.53% of its total revenue.
The smallest region for Abbott Laboratories is the NETHERLANDS, which represents 2.68% of its total revenue.
Continue reading...

Summary Table

Geography (Percent Share) 2022 2023 2024
C [H] 4.89% 5.62% 0%
CANADA 2.93% 0% 0%
GERMANY 5.36% 5.85% 0%
INDIA 3.78% 4.36% 0%
JAPAN 4.43% 3.77% 0%
NETHERLANDS 0% 2.68% 0%
Non-US 34% 35.11% 0%
SWITZERLAND 3.06% 4.08% 0%
UNITED STATES 41.56% 38.53% 0%
Total Revenue 100% 100% 100%

The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.

  • C [H] revenue decreased -100% ($2.25B) from $2.25B (in 2023) to $0.00 (in 2024).
  • GERMANY revenue decreased -100% ($2.35B) from $2.35B (in 2023) to $0.00 (in 2024).
  • INDIA revenue decreased -100% ($1.75B) from $1.75B (in 2023) to $0.00 (in 2024).
  • JAPAN revenue decreased -100% ($1.51B) from $1.51B (in 2023) to $0.00 (in 2024).
  • NETHERLANDS revenue decreased -100% ($1.07B) from $1.07B (in 2023) to $0.00 (in 2024).
  • Non-US revenue decreased -100% ($14.08B) from $14.08B (in 2023) to $0.00 (in 2024).
  • SWITZERLAND revenue decreased -100% ($1.64B) from $1.64B (in 2023) to $0.00 (in 2024).
  • UNITED STATES revenue decreased -100% ($15.45B) from $15.45B (in 2023) to $0.00 (in 2024).
  • Continue reading...

    Summary Table

    Region 2022 2023 2024
    C [H] $2.13B - $2.25B
    5.63%
    - -
    CANADA $1.28B - - - - -
    GERMANY $2.34B - $2.35B
    0.21%
    - -
    INDIA $1.65B - $1.75B
    6.12%
    - -
    JAPAN $1.93B - $1.51B
    21.69%
    - -
    NETHERLANDS - - $1.07B - - -
    Non-US $14.84B - $14.08B
    5.10%
    - -
    SWITZERLAND $1.34B - $1.64B
    22.60%
    - -
    UNITED STATES $18.14B - $15.45B
    14.83%
    - -
    Total Revenue $43.65B - $40.11B
    8.12%
    -
    100.00%